Business ❯ Corporate Governance ❯ Shareholder Rights ❯ Class Action Lawsuits

Investor Advocacy

Skye Bioscience Hit With Securities Class Action Over Nimacimab Disclosures as Firms Court Lead Plaintiff

Investor-rights firms are inviting Skye shareholders to seek the lead-plaintiff role by January 16, 2026.